Eikon Therapeutics, Inc. Common Stock (EIKN) — Long-term Investment Intensity
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Long-term Investment Intensity of 9.9% as of March 2026. Long-term investments of $83.83 Million represent 9.9% of total assets of $850.83 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital position of Eikon Therapeutics, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for Eikon Therapeutics, Inc. Common Stock (None–None)
The table below presents the year-by-year Long-term Investment Intensity for Eikon Therapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Eikon Therapeutics, Inc. Common Stock balance sheet assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|